002907 华森制药
2026/03 -
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--015,41421,94325,975
投资性房地产63,710-0.63%64,11268,32871,15718,970
固定资产462,752-2.73%475,744527,896567,397604,288
在建工程17,74334.50%13,19210,19125,77617,516
无形资产202,508-3.29%209,393125,888107,13675,257
商誉0--0000
其他非流动资产129,905-4.39%135,876138,488163,406167,711
876,618-2.42%898,317886,205956,815909,717

流动资产
货币资金296,1177.94%274,338456,553437,565503,529
应收账款203,85210.06%185,224174,843169,364216,844
存货130,692-6.00%139,028140,125151,677114,756
其他流动资产527,836-0.46%530,252259,824136,034121,821
1,158,4972.63%1,128,8421,031,345894,639956,949

流动负债
短期借款0--0000
应付票据0--0000
应付帐款70,4641.31%69,55664,36355,23348,043
其他流动负债177,125-9.11%194,885147,671133,445163,277
247,589-6.37%264,440212,034188,677211,320
流动资产净值910,9085.38%864,401819,310705,962745,630
资产总额减流动负债1,787,5261.41%1,762,7181,705,5151,662,7771,655,347

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债51,408-7.42%55,53145,51744,85644,957
51,408-7.42%55,53145,51744,85644,957

总权益
    实收股本417,5960.00%417,596417,596417,596417,596
    储备项目1,306,7832.60%1,273,7251,242,4021,200,3251,192,794
股东权益1,724,3791.95%1,691,3221,659,9981,617,9211,610,390
非控股权益11,739-26.01%15,865000